Call 1 (888) 460-6556 to speak with a counselor.

(Source: Drug and Alcohol Dependence)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

{ Comments on this entry are closed }

Call 1 (888) 460-6556 to speak with a counselor.

(Source: Drug and Alcohol Dependence)

MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find the best Christmas presents too.

{ Comments on this entry are closed }

Buprenorphine + Naloxone plus Naltrexone for the Treatment of Cocaine Dependence: The Cocaine Use Reduction with Buprenorphine (CURB) Study

March 6, 2016

ConclusionsBuprenorphine + naloxone, used in combination with naltrexone, may be associated with reductions in cocaine use among people who meet DSM‐IV criteria for cocaine dependence and past or current opioid dependence or abuse. This article is protected by copyright. All rights reserved. (Source: Addiction) MedWorm Sponsor Message: Directory of the best January Sales in the UK. Find […]

Read the full article →

Letter Reveals Drug Courts Lobbied Against Key Addiction Treatment

February 10, 2016

WASHINGTON – The head of a nonprofit organization that represents drug courts lobbied the U.S. Department of Health and Human Services against increasing access to a key addiction treatment. In an Aug. 19, 2014, letter obtained by The Huffington Post through an open records request, West Huddleston, the then-CEO of the National Association of Drug Court […]

Read the full article →

Letter Reveals Drug Courts Lobbied Against Key Addiction Treatment

February 10, 2016

WASHINGTON – The head of a nonprofit organization that represents drug courts lobbied the U.S. Department of Health and Human Services against increasing access to a key addiction treatment. In an Aug. 19, 2014, letter obtained by The Huffington Post through an open records request, West Huddleston, the then-CEO of the National Association of Drug Court […]

Read the full article →

W-18, a synthetic opiate 100 times more potent than fentanyl

February 4, 2016

W-18 Last August, Canadian police seized 110 illegal fentanyl pills at a home in Alberta province. Yesterday, Global News reported that some of the pills have tested positive for an extremely potent opioid called W-18. This is certainly a disturbing development, since W-18 is a μ-receptor agonist 100 times more potent than fentanyl. According to […]

Read the full article →

W-18, a synthetic opiate 100 times more potent than fentanyl

February 4, 2016

W-18 Last August, Canadian police seized 110 illegal fentanyl pills at a home in Alberta province. Yesterday, Global News reported that some of the pills have tested positive for an extremely potent opioid called W-18. This is certainly a disturbing development, since W-18 is a μ-receptor agonist 100 times more potent than fentanyl. According to […]

Read the full article →

Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence

February 1, 2016

Objectives: The aim of the study was to evaluate buprenorphine-naloxone effects on the QTc in youth with opioid dependence. Buprenorphine is a partial agonist that is an effective treatment for opioid dependence. Compared with methadone, it has a lower risk of QTc prolongation in adults, but is less studied in the youth. It may also […]

Read the full article →

Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence

February 1, 2016

Objectives: The aim of the study was to evaluate buprenorphine-naloxone effects on the QTc in youth with opioid dependence. Buprenorphine is a partial agonist that is an effective treatment for opioid dependence. Compared with methadone, it has a lower risk of QTc prolongation in adults, but is less studied in the youth. It may also […]

Read the full article →

Management of patients with issues related to opioid safety, efficacy and/or misuse: a case series from an integrated, interdisciplinary clinic.

January 30, 2016

CONCLUSIONS: The core components of our approach-biopsychosocial assessment and multimodal treatment planning with an emphasis on promoting functional goals and safety using clear communication and a patient-centered stance-should guide providers in the management of similar clinical scenarios. More evidence is needed to definitively guide specific interventions and points of clinical equipoise. PMID: 26818474 [PubMed – […]

Read the full article →